U.S. government report on “notorious markets” known for counterfeiting and other violations of intellectual property says ...

Diamyd Medical provides an update following the receipt of final meeting minutes from a positive Type C meeting with the U.S. Food and Drug Administration ...

Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...